FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/063363 [Registered on: 29/02/2024] Trial Registered Prospectively
Last Modified On: 29/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) 
Study Design  Single Arm Study 
Public Title of Study   To check the efficacy OF Grudhrasi Kwath in Grudhrasi Sciatica  
Scientific Title of Study   Assesment of Grudhrasi Kwath in the Treatment of Grudhrasi Sciatica. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vitrag Shrenik Doshi 
Designation  PG Scholar 
Affiliation  Bharti Vidyapeeth Deemed to be University College of Ayurved Pune 
Address  Bharti Vidyapeeth Deemed to be University College of Ayurved Department of Kayachikitsa Katraj Dhankawadi Campus Pune

Pune
MAHARASHTRA
411043
India 
Phone  9130259000  
Fax    
Email  vitrag.doshi-ayurved@bvp.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dattatraya L Shinde 
Designation  Professor 
Affiliation  Bharti Vidyapeeth Deemed to be University College of Ayurveda Pune  
Address  Bharti Vidyapeeth Deemed to be University College of Ayurved Department of Kayachikitsa Katraj Dhankawadi Campus Pune

Pune
MAHARASHTRA
411043
India 
Phone  9890111954  
Fax    
Email  dshinde249@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Dattatraya L Shinde 
Designation  Professor 
Affiliation  Bharti Vidyapeeth Deemed to be University College of Ayurveda Pune  
Address  Bharti Vidyapeeth Deemed to be University College of Ayurved Department of Kayachikitsa Katraj Dhankawadi Campus Pune

Pune
MAHARASHTRA
411043
India 
Phone  9890111954  
Fax    
Email  dshinde249@gmail.com  
 
Source of Monetary or Material Support  
Bharati Vidyapeeth deemed to be university College of Ayurved and Hospital 
 
Primary Sponsor  
Name  Dr Vitrag S Doshi 
Address  Bharati Vidyapeeth Deemed To Be University College Of Ayurved Katraj Dhankawadi Campus Pune 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vitrag S Doshi  Bharati Vidyapeeth Deemed to be University College of Ayurved and Hospital  Department of Kaychikitsa Second floor, passage Area Room No- 1,Room Name-Head of Department ( Dr.Dattatray.L.Shinde M.D PhD Professor Dept of Kaychikitsa pune Maharashtra
Pune
MAHARASHTRA 
9130259000

vitrag.doshi-ayurved@bvp.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Bharati Vidyapeeth Deemed to be University Pune India College of Ayurved Pune Satara Road Pune 411043 ETHICS COMMITTEE [BV(DU)COA EC]  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M543||Sciatica. Ayurveda Condition: GRUDHRASI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Grudhrasi Kwatha, Reference: Sharangadhara Samhita, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Ushna Jala), Additional Information: Grudhrasi Kwatha will be prepared as mentioned in Sharangadhara Samhita Madhyam Khanda.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1 Patients of age between 18-70 years of both Gender.
2 Patients with presence of Ruk(pain), Toda (Pricking Pain), Stambha (Stiffness), and Spandan (Twitching) in the Spik, Kati (Waist) Uru ,Janu( Knee joint), Jangha (calf muscles) and Pada ( feets)
 
 
ExclusionCriteria 
Details  1 Patients suffering from several traumatic injury,spinal tumor and spinal deformity .
2 Patients of Grudhrasi associated with any of following disorder will be excluded from study such as- Rheumatoid arthritis, auto immune disease.
c)Any other inflammatory disorder like Tubercular Arthritis, Septic Arthritis, Tuberculosis of spine.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Reduction in Straight Raise Test Degrees   28 days  
 
Secondary Outcome  
Outcome  TimePoints 
75% reduction Improvement in SLR Test Improvement in vas scales.
Improvement in Walking time
 
Baseline, 7th,14th,21th,28th and 30th Day follow up. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "40"
Final Enrollment numbers achieved (India)="40" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   05/03/2024 
Date of Study Completion (India) 28/03/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Article in process 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
The study will conducted after obtaining permission from institutional  ethical community & will be registered CTRI India
As per inclusion criteria patient will be selected & screening done at OPD
Subjective & Objective parameters will be checked & noted.
Whole research procedure & Aim will be clearly informed to patients hence Form will be signed by enrolled participants & case report form will be filled.
Conduct of trial
Patient will be examined in OPD on the first day of visit for sign & symptoms of Grudhrasi  with Straight Leg Raise Test. After investigation (  X- Rays Lumbar Spine Anterio-Posterio/Lateral)
Patients will be allocated for treatment.pre assesment will be done on 0 days 
Once patients is enrolled in study protocol Grudhrasi Kwath will be given to patients for 30 days.
Follow up will conducted on 7, 14,21,28 day. respectively 30 days will be  last chakeup.
 Patients will be observed & if patients  not following treatment  protocol or not willing to continue treatment can be considered as a droup out aversion to treatment unwanted effects. If any side effects occurs then proper treatment adviced.
On day one-  Patients will be observed for Subjective parameters ( sign/ Symptoms) 
On Day Two- Test drug will be given to patients up to 30 days then asked to Consume as per Standard guidelines given to then on the day Two.


 
Close